Clinical trials
Phase 1/2 Burkitt Lymphoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 11 |
| Recruiting | 8 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shenzhen BinDeBio Ltd. | 3 |
| 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2 |
| AstraZeneca | 2 |
| Liping Dou | 2 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| Beijing Biotech | 1 |
| Excyte Biopharma Ltd | 1 |
| Henan Cancer Hospital | 1 |
| Juventas Cell Therapy Ltd. | 1 |
| Kunming Hope of Health Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burkitt Lymphoma | 21 |
| Lymphoma | 5 |
| Lymphoma, B-Cell | 5 |
| Recurrence | 5 |
| Multiple Myeloma | 2 |
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Renal Cell | 1 |
| Colorectal Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.